ILDONG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,070 KRW | +1.34% |
|
+1.76% | -17.02% |
| 2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
| 2023 | Il Dong Pharmaceutical Introduces New R&D Unit Yunovia | MT |
Chart calendar Ildong Pharmaceutical Co., Ltd.
990179eb673a3a13132c3234ed1.enV_kdp9sId5ONGTlis6rCrlOvPK9XuJQRwWiu_Uy6g.P0Ma55cegPNAVeHf8Glw2meGbbe8ok7cI1oiu8KNh-EpRxjytQzfsit3gA~28a0acbde8bea6df439f5aa0b823b685
Upcoming events on Ildong Pharmaceutical Co., Ltd.
Past events on Ildong Pharmaceutical Co., Ltd.
| 2024-02-07 | Q4 2023 Earnings Release |
| 2023-05-14 | Q1 2023 Earnings Release |
| 2023-03-15 | Q4 2022 Earnings Release |
| 2023-01-12 | Roadshow - Day - 2 |
| 2023-01-11 | Roadshow - Day - 1 |
| 2022-11-13 | Q3 2022 Earnings Release |
| 2022-08-15 | Interim 2022 Earnings Release |
| 2022-05-15 | Q1 2022 Earnings Release |
| 2021-08-16 | Interim 2021 Earnings Release |
| 2021-05-16 | Q1 2021 Earnings Release |
| 2021-03-17 | FY 2020 Earnings Release |
| 2020-03-29 | FY 2019 Earnings Release |
| 2019-11-13 | Q3 2019 Earnings Release |
| 2019-05-14 | Q1 2019 Earnings Release |
| 2018-02-19 | FY 2017 Earnings Release |
Past dividends on Ildong Pharmaceutical Co., Ltd.
| 2018-12-26 | Annual 400 KRW |
| 2017-12-26 | Annual 400 KRW |
| 2016-12-27 | Annual 300 KRW |
Annual results
| Fiscal Period | December | 2019 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 517 532 -2.78% | 636 645 -1.42% | 598 597 0.24% | 635 |
|
EBITDA Billions KRW | Released Forecast Spread | 25,7 53,8 -52.17% | -43,0 -15,0 -186.54% | 0,00 -17,0 - | 79,0 |
|
EBIT Billions KRW | Released Forecast Spread | -1,90 26,1 -107.28% | -72,1 -41,0 -75.97% | -40,9 -41,0 0.21% | 56,0 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -82,0 -96,5 14.98% | 34,9 |
|
Net income Billions KRW | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -71,5 -93,7 23.71% | 31,4 |
|
EPS KRW | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 -3 338 - | 1 119 |
| Announcement Date | 14/02/20 | 09/02/23 | 08/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2023 Q4 |
|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 162 143 13.31% | 149 148 0.99% |
|
EBIT Billions KRW | Released Forecast Spread | -22,0 17,0 -229.59% | |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,02 -14,5 100.12% | |
|
Net income Billions KRW | Released Forecast Spread | 7,50 -14,7 151.03% | |
| Announcement Date | 27/07/22 | 08/02/24 |
More events
Past sector events for Ildong Pharmaceutical Co., Ltd.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A249420 Stock
- Calendar Ildong Pharmaceutical Co., Ltd.
